Profile: CLS Bank's Bozian on regulatory co-ops and CCP settlement risk

Clearly settled


Reform of the over-the-counter derivatives market is still being finalised, but a new world – built around mandatory clearing, electronic execution and reporting – is beginning to take shape. These measures will help limit systemic counterparty risks, regulators hope, either by mitigating it directly or by shining a light into the previously opaque OTC market so exposures are not allowed to reach dangerous concentrations.

But national interests are making the realisation of this vision difficult

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: